MassMEDIC will conduct its Annual MedTech Showcase on October 10th, at the Westin Seaport Hotel, Boston. Medtech start-up executives are invited to conduct 10-minute pitches at this conference. 

The federal government renews funding for the Centre for the Commercialization of Regenerative Medicine (CCRM) and the Centre for Probe Development and Commercialization (CPDC) in Hamilton through the Networks of Centres of Excellence (NCE) program.

Grand Challenges Canada seeks bold and innovative ideas for products, services and implementation models that will transform how challenges related to sexual and reproductive health and rights are addressed in low- and middle-income countries. 

The University of Toronto announces plans to build a new 14-storey Innovation Centre, replacing the western portion of the Banting and Best complex, located at the corner of College Street and University Avenue, with expected completion in 2021.

Swift Medical CEO Carlo Perez was recognized as one of the finalists for EY Entrepreneur of the Year 2018. The awards recognize entrepreneurial spirit and purpose-driven leadership for the future of the healthcare industry.

Canadian Technology Accelerator (CTA) for Health IT in Philadelphia is a three-month mentoring and orientation program for small and medium-sized digital health enterprises, with a five-day orientation in Philadelphia with key members of the city's healthcare community.

A new round of Genome Canada’s Genomic Applications Partnership Program (GAPP) funding is now available for research collaborations on developing genomics-derived technologies.

Canadian Technology Accelerator (CTA) San Francisco – Life Sciences is an intensive program run by the Trade Commissioner Service (TCS) team in San Francisco. It offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector. The program is accepting applications for the winter 2018 cohort, which will run November 2018 – February 2019.

Biotechnology Focus magazine is conducting a survey to gauge Canada’s innovation culture. In support of Global Biotech Week (Sept 24-30), add your voice to the Innovation Report by taking this quick survey by July 27th.

VentureLAB brings you a collaborative workshop offering real-world, practical tools, frameworks and tips for commercializing digital healthcare solutions in the U.S. market.

KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.

JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode. 

Toronto’s Antibe Therapeutics released positive secondary endpoint data, conducted in their 244 patients, from the recent Phase 2B Gastrointestinal safety study for its lead drug, ATB-346. These results are consistent with the primary endpoint data, previously released on March 20, 2018.